Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating epilepsy, and preparation method and application thereof

A drug and epilepsy technology, applied in the field of medicine, can solve the problems of inability to completely cure epilepsy, difficult for patients to accept, strong drug dependence, etc., and achieve the effects of no toxic side effects and allergic reactions, low price, and low dosage.

Inactive Publication Date: 2017-05-31
ZHENGZHOU ZHANGMENG NETWORK TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, carbamazepine, yingal, epileptamine, etc., not only cannot completely cure epilepsy, but also fail to achieve the purpose of treatment, but also have large side effects, strong drug dependence, and produce unavoidable side effects such as mental depression, IQ, and mental retardation. Therefore, it is not easy to be accepted by patients
In addition, often taking anti-epileptic western medicines can easily lead to drug adaptation. If you want to maintain a certain curative effect, you have to increase the dose, forming a vicious circle
Traditional Chinese medicine is effective in treating epilepsy with few side effects, but the treatment cycle is long and the reduction is slow, which is not conducive to the recovery of patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] In an embodiment of the present invention, a drug for treating epilepsy is composed of the following raw materials in parts by weight: 1 part of puerarin flavonoids, 6 parts of allicin, 11 parts of rubyricol ester, and 15 parts of anisodamine.

[0019] Anisodamine was mixed with 10.8 times the mass of deionized water to prepare anisodamine solution. Mix and grind allicin and rubricol ester, add anisodamine solution, and stir at 52°C for 30 minutes to prepare mixture A. The mixture A was ultrasonically treated at a temperature of 45°C for 20min with an ultrasonic power of 700W, then pueraria flavonoids were added, and microwaved for 3min with a microwave power of 800W, then stirred at a temperature of 63°C until dry and granulated to obtain the drug .

Embodiment 2

[0021] In the embodiment of the present invention, a drug for treating epilepsy is composed of the following raw materials in parts by weight: 5 parts of puerarin flavonoids, 14 parts of allicin, 19 parts of rubyricol ester, and 23 parts of anisodamine.

[0022] Anisodamine was mixed with 10.8 times the mass of deionized water to prepare anisodamine solution. Mix and grind allicin and rubricol ester, add anisodamine solution, and stir at 52°C for 33 minutes to prepare mixture A. The mixture A was ultrasonically treated at a temperature of 45°C for 20min with an ultrasonic power of 700W, then pueraria flavonoids were added, and microwaved for 3min with a microwave power of 800W, then stirred at a temperature of 63°C until dry and granulated to obtain the drug .

Embodiment 3

[0024] In the embodiment of the present invention, a drug for treating epilepsy is composed of the following raw materials in parts by weight: 2 parts of puerarin flavonoids, 8 parts of allicin, 13 parts of rhubarol ester, and 17 parts of anisodamine.

[0025] Anisodamine was mixed with 10.8 times the mass of deionized water to prepare anisodamine solution. Mix and grind allicin and rubricol ester, add anisodamine solution, and stir at 52°C for 31 minutes to prepare mixture A. The mixture A was ultrasonically treated at a temperature of 45°C for 20min with an ultrasonic power of 700W, then pueraria flavonoids were added, and microwaved for 3min with a microwave power of 800W, then stirred at a temperature of 63°C until dry and granulated to obtain the drug .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating epilepsy, and a preparation method and application thereof. The medicine is prepared from the following raw materials in parts by weight: 1 to 5 parts of radix puerariae flavone, 6 to 14 parts of allicin, 11 to 19 parts of cuscohygrine, and 15 to 23 parts of anisodamine. The preparation method comprises the steps of mixing and grinding the allicin and the cuscohygrine; adding an anisodamine solution, stirring for 30 to 33min at the temperature of 52 DEG C, and carrying out ultrasonic treatment for 20min at the temperature of 45 DEG C, wherein the ultrasonic power is 700W; then adding the radix puerariae flavone, and carrying out ultrasonic treatment for 30min, wherein the ultrasonic power is 800W; stirring at the temperature of 63 DEG C until dry, and pelleting. The medicine for treating epilepsy provided by the invention is used for treating epilepsy, and can achieve the aim of treating both symptoms and root causes; is fast in effect, good in long-term follow-up result, and uneasy to recur. The medicine provided by the invention is less in dosage, has no any toxic and side effect and anaphylactic reaction, and is high in cure rate, low in recurrence rate, low in price, and easily acceptable to patients.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating epilepsy and its preparation method and application. Background technique [0002] Epilepsy, also commonly known as lamb's wind, is a chronic brain disorder caused by a variety of etiologies. It is a chronic disease in which the sudden abnormal discharge of brain neurons leads to transient brain dysfunction. It manifests as disturbance of consciousness with sudden onset and sudden cessation, body convulsions, foaming at the mouth, body convulsions, eyes turned up, and normal people after waking up. There are many causes of epilepsy, common causes include poisoning, hypoxia, trauma, infection, brain disease, congenital disease, metabolic disease, heart and cerebrovascular disease, etc. [0003] Western medicine and western medicine have its advantages in controlling epileptic seizures, but too strong inhibitory effect will cause toxic side effects on brai...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/352A61K31/255A61K31/46A61K31/4025A61P25/08
CPCA61K31/352A61K31/255A61K31/4025A61K31/46
Inventor 不公告发明人
Owner ZHENGZHOU ZHANGMENG NETWORK TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com